International Society for the Study of Vascular Anomalies
MENU
Back to Top

International Society for the
Study of Vascular Anomalies

Thank You For Attending the ISSVA World Congress 2024

Thank you for making the ISSVA World Congress 2024: The Latest in Vascular Anomalies a resounding success! 

Claim CME:

Physicians (ACCME) Credit Designation Amedco LLC designates this live activity for a maximum of 25.25 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Claim CME Credits
1. Go to http://issva.cmecertificateonline.com/
2. Click on the “World Congress 2024” link.
3. Evaluate the meeting.
4. Save/Download/Print all pages of your certificate for your records.

Click here to read the full Learner Notification regarding disclosures of faculty and planners, and additional information regarding CME.

Questions? Email Certificate@AmedcoEmail.com

ISSVA World Congress 2024 Recordings:

Recordings will open within two weeks and be available to those who purchased virtual or in-person registration to the Congress. Attendees will receive an email when the recordings are accessible.

Upcoming Meetings

  • ISSVA Debates & Updates 2025 will be held 23-25 April 2025 in Paris, France

  • ISSVA World Congress 2026 will be held 19-22 May 2026 in Philadelphia, USA

Resources for Physicians, Researchers & Allied Health

Please note the recent posting on the VASCERN-VASCA website: "Consensus Statement on Sirolimus and Infertility

Find a Specialist: to find a specialist who treats patients with vascular anomalies, please visit out Find a Specialist page, which includes all ISSVA members who have opted in to allow their information to be shown on the public side of the website.

Patient Advocacy Organizations: Since the establishment of ISSVA in 1992, collaborations have been integral to the growth, awareness and improved diagnosis and treatment of patients with vascular anomalies. ISSVA networks with patient advocacy organizations, which support ISSVA's initiatives and are a key contributor to providing patients with valuable educational resources while advocating for individuals with vascular anomalies. Find a Patient Advocacy Organization.

Membership

ISSVA Membership is open to physicians and biomedical scientists with an interest in vascular anomalies or you can apply for Affiliate membership if you are a nurse, other health care professional or other individual who is actively involved in the field of vascular anomalies. Learn More About Types of ISSVA Membership.

Membership Benefits

  • Receive a discounted registration fee to attend ISSVA meetings
  • Receive a discounted fee to publish in the open access Journal of Vascular Anomalies (JoVA)
  • Connect with world leaders in the field via online Message Boards (see below)
  • Receive exposure for you and your vascular anomalies center by being listed on the ISSVA website
  • Receive the ISSVA newsletter, updates, and other meetings of interest

Become an ISSVA Member Today

Journal of Vascular Anomalies (JoVA)

The Journal of Vascular Anomalies (JoVA), an online-only open access journal dedicated to the scientific investigation, diagnosis, and treatment of congenital and acquired human vascular lesions, will support ISSVA's mission to spread education to physicians, researchers, allied health, and other professionals interested in the field of Vascular Anomalies.

The journal’s focus includes novel approaches, evidence-based research, critical reviews and emerging science from a broad array of medical, surgical, radiologic, and scientific disciplines. As a peer-reviewed journal, we cannot guarantee acceptance, however strongly encourage you to consider submission to further share your knowledge with the vascular anomalies community.

We are currently accepting submissions of original scientific research (molecular, genetic, histologic); original clinical studies (prospective, retrospective, case series); contemporary reviews; evidence based reviews; how I do it?; case reports; and letters to the editor.

Submit Manuscript